New drugs

First oral GLP-1 agonist launched for type II diabetes

First oral GLP-1 agonist launched for type II diabetes

Prescribers can now consider a GLP-1 agonist as an...

New rapidly acting insulin launched

New rapidly acting insulin launched

Lyumjev is a new 'ultra rapidly acting' formulation...

Transdermal estradiol spray offers new treatment option for HRT

Transdermal estradiol spray offers new treatment option for HRT

Lenzetto (estradiol) is the first transdermal spray...

Ketamine-derived nasal spray provides new option for resistant depression

Ketamine-derived nasal spray provides new option for resistant depression

Spravato (esketamine) works in a different way to existing...

New e-cigarette alternative launched on prescription

New e-cigarette alternative launched on prescription

Voke, a new nicotine inhaler, is available to prescribe...

Low-dose oestrogen pessary for vaginal menopause symptoms

Low-dose oestrogen pessary for vaginal menopause symptoms

Imvaggis (estriol) is a new treatment for vaginal symptoms...

New low-dose oestrogen gel for vaginal menopause symptoms

New low-dose oestrogen gel for vaginal menopause symptoms

Blissel is a topical gel containing 50 microgram/g...

Further monthly injectable migraine prophylactic launched

Further monthly injectable migraine prophylactic launched

With the launch of Emgality (galcanezumab), prescribers...

New non-oestrogen treatment for vaginal menopause symptoms

New non-oestrogen treatment for vaginal menopause symptoms

Intrarosa (prasterone) is a new topical treatment for...

New migraine prophylactic for monthly or quarterly injection

New migraine prophylactic for monthly or quarterly injection

Fremanezumab (Ajovy) is a monoclonal antibody licensed...